- Home
- VRDN vs IART Comparison
VRDN vs IART Comparison
Compare VRDN & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- IART
- Stock Information
- Founded
- VRDN 2006
- IART 1989
- Country
- VRDN United States
- IART United States
- Employees
- VRDN N/A
- IART N/A
- Industry
- VRDN Medical Specialities
- IART Medical/Dental Instruments
- Sector
- VRDN Health Care
- IART Health Care
- Exchange
- VRDN Nasdaq
- IART Nasdaq
- Market Cap
- VRDN 1.5B
- IART 1.3B
- IPO Year
- VRDN N/A
- IART 1995
- Fundamental
- Price
- VRDN $20.14
- IART $23.04
- Analyst Decision
- VRDN Strong Buy
- IART Hold
- Analyst Count
- VRDN 10
- IART 9
- Target Price
- VRDN $37.25
- IART $30.88
- AVG Volume (30 Days)
- VRDN 1.1M
- IART 1.1M
- Earning Date
- VRDN 11-12-2024
- IART 11-04-2024
- Dividend Yield
- VRDN N/A
- IART N/A
- EPS Growth
- VRDN N/A
- IART N/A
- EPS
- VRDN N/A
- IART N/A
- Revenue
- VRDN $302,000.00
- IART $1,564,920,000.00
- Revenue This Year
- VRDN N/A
- IART $6.71
- Revenue Next Year
- VRDN N/A
- IART $6.08
- P/E Ratio
- VRDN N/A
- IART N/A
- Revenue Growth
- VRDN N/A
- IART 1.45
- 52 Week Low
- VRDN $11.40
- IART $16.81
- 52 Week High
- VRDN $27.20
- IART $45.42
- Technical
- Relative Strength Index (RSI)
- VRDN 36.38
- IART 58.85
- Support Level
- VRDN $22.40
- IART $23.03
- Resistance Level
- VRDN $27.20
- IART $26.14
- Average True Range (ATR)
- VRDN 1.36
- IART 1.14
- MACD
- VRDN -0.41
- IART 0.05
- Stochastic Oscillator
- VRDN 6.37
- IART 59.20
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.